Aurora Cannabis vs Harrow
Harrow is the larger business, with $272m of revenue in fiscal 2025 against $232m for Aurora Cannabis (1.2 times as much). Harrow grew faster (36.4% against 11.7%). Harrow kept more of each dollar of sales as profit: a net margin of -1.9% against -42.4%.
| Latest fiscal year | Aurora CannabisACB, 2026 | HarrowHROW, 2025 |
|---|---|---|
| Revenue | $232m | $272m |
| Revenue growth | 11.7% | 36.4% |
| Net income | −$98.4m | −$5.1m |
| Operating margin | — | — |
| Net margin | -42.4% | -1.9% |
| Return on equity | -25.9% | -8.4% |
| Free cash flow | −$9.8m | $43.0m |
| Cash | $46.4m | $72.9m |
| Total debt | $0 | $250m |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | — |
| Market value | $295m | $1.06bn |
| Price vs our value range | — | Above our value range |
| Moat score | — | 26 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 4 buys, 7 sales |